Screening for rare fatal disease too costly: study | Reuters

Links shared publicly online about this topic.

  • 1,313
    total visits

Screening for rare fatal disease too costly: study | Reuters

reuters.com

NEW YORK (Reuters Health) - Screening all pregnant women for a rare but fatal genetic disease is too expensive, researchers say in a new report that adds to a recent controversy about whether genetic tests

View full resource at reuters.com

Tags: Genetic, Disease and Condition, Lab Test, Women's Health, Pregnancy

  • Share

Most Recently Shared on March 15, 2010 at 2:06 pm By:

HealthPassion HealthPassion

Screening for rare fatal disease too costly: study: NEW YORK (Reuters Health) - Screening all pregnant women for a... http://bit.ly/bS4T3D

2 years ago...

Screening for rare fatal disease too costly: study | Reuters

reuters.com — “NEW YORK (Reuters Health) - Screening all pregnant women for a rare but fatal genetic disease is too expensive, researchers say in a new report that adds to a recent controversy about whether genetic testsView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on March 15, 2010 at 5:12 pm By:

hrana Hisham Rana, MD Doctor and Physician

Research: Screening for rare fatal disease too costly http://bit.ly/bPTbZO - #health #medicine

2 years ago...

Screening for rare fatal disease too costly: study | Reuters

feeds.reuters.com — “NEW YORK (Reuters Health) - Screening all pregnant women for a rare but fatal genetic disease is too expensive, researchers say in a new report that adds to a recent controversy about whether genetic testsView full resource at feeds.reuters.com

  • View Related
  • Share

Most Recently Shared on March 15, 2010 at 3:21 pm By:

HITpol HealthIT Policy Health News and Health IT

Screening for rare fatal disease too costly: study: NEW YORK (Reuters Health) - Screening all pregnant women for a... http://bit.ly/aXas6H

2 years ago...

Screening for rare fatal disease too costly: study | Reuters

reuters.com — “NEW YORK (Reuters Health) - Screening all pregnant women for a rare but fatal genetic disease is too expensive, researchers say in a new report that adds to a recent controversy about whether genetic testsView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on March 15, 2010 at 2:53 pm By:

ivanoransky Ivan Oransky Doctor and Health Communicator

Screening for spinal muscular atrophy (SMA) is too expensive, says study. SMA Foundation declines to comment http://bit.ly/9R2osH

2 years ago...

Screening for rare fatal disease too costly: study | Reuters

feeds.reuters.com — “NEW YORK (Reuters Health) - Screening all pregnant women for a rare but fatal genetic disease is too expensive, researchers say in a new report that adds to a recent controversy about whether genetic testsView full resource at feeds.reuters.com

  • View Related
  • Share

Most Recently Shared on March 15, 2010 at 2:51 pm By:

Screening for rare fatal disease too costly: study | Reuters

feeds.reuters.com — “NEW YORK (Reuters Health) - Screening all pregnant women for a rare but fatal genetic disease is too expensive, researchers say in a new report that adds to a recent controversy about whether genetic testsView full resource at feeds.reuters.com

  • View Related
  • Share

Most Recently Shared on March 15, 2010 at 1:12 pm By:

Advertisement